Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 1Pancreatic Neoplasms 1

Interventions

Specimen Handling 80Fluorouracil 75Oxaliplatin 67Magnetic Resonance Spectroscopy 61Leucovorin 59Bevacizumab 56Gemcitabine 53Biopsy 41Irinotecan 37Capecitabine 37pembrolizumab 35Cisplatin 35Nivolumab 33Cetuximab 32130-nm albumin-bound paclitaxel 28Paclitaxel 27durvalumab 26atezolizumab 21Folfox protocol 20Radiotherapy 17Carboplatin 17Taxes 16dehydroftorafur 15Radiation 14Cyclophosphamide 14X-Rays 13Albumin-Bound Paclitaxel 13trastuzumab deruxtecan 12fludarabine 12Surgical Procedures, Operative 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
DEAE-Dextran × Gastrointestinal × 30 days × Clear all
NCT07607119 2026-05-28

PULSAR Combined With Immunotherapy for Unresectable Locally Advanced Gastric Cancer

Samsung Medical Center

Phase NA Recruiting
53 enrolled
Gastrointestinal

Stomach Neoplasms

NCT07595172 2026-05-19

NALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer

West China Hospital

Phase 1/2 Recruiting
55 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡